N※N

Nebraska Bill Seeks to Expand Alzheimer's Coverage

  //food-wine.news-articles.net/content/2026/03/09 .. a-bill-seeks-to-expand-alzheimer-s-coverage.html
  Published in Food and Wine on Monday, March 9th 2026 at 3:04 GMT by KLTN
      Locales: Nebraska, UNITED STATES

LINCOLN, Neb. - March 9, 2026 - A crucial bill, LB73, is currently under consideration by the Nebraska Legislature, aiming to significantly expand insurance coverage for Alzheimer's disease testing and treatments. Introduced by Senator Lynne Walz, the legislation addresses a critical gap in healthcare access for individuals at risk of or diagnosed with this devastating neurodegenerative disease.

Alzheimer's disease is a growing public health crisis. According to the Alzheimer's Association's 2025 Facts and Figures report, over 6.7 million Americans are currently living with Alzheimer's, and this number is projected to nearly double to 11.5 million by 2050. The economic impact is also staggering, with healthcare costs and lost productivity estimated at over $300 billion annually. Nebraska, like the rest of the nation, is facing an increasing number of residents affected by Alzheimer's, placing a strain on families, caregivers, and the healthcare system.

Currently, the landscape of insurance coverage for Alzheimer's related services in Nebraska is inconsistent and often inadequate. Diagnostic tests, like amyloid PET scans and cerebrospinal fluid biomarkers, can be expensive and are not always covered by standard insurance plans. This presents a significant barrier to early detection. Even when a diagnosis is made, access to newer, potentially disease-modifying treatments, such as Aduhelm and Leqembi (and emerging therapies in the pipeline), is often restricted due to cost and coverage limitations.

Senator Walz emphasizes the urgency of addressing this issue. "Right now, so many people don't get diagnosed until it's too late," she stated. "This bill would remove a barrier for people seeking a diagnosis and treatment." The 'too late' aspect is vital. While there is no cure for Alzheimer's, emerging research suggests that early intervention, particularly with these newer treatments, can potentially slow the progression of the disease and improve quality of life. Delaying diagnosis means missing a critical window for these interventions.

LB73 seeks to mandate that all insurance plans operating within Nebraska cover both diagnostic tests and a range of treatments associated with Alzheimer's. This includes not just pharmacological interventions but also crucial supportive services like cognitive behavioral therapy, memory care programs, and respite care for caregivers. The bill's proponents argue that these comprehensive services are essential for holistic patient management.

The financial burden on families impacted by Alzheimer's is often immense. Beyond medical expenses, there are costs associated with long-term care, home modifications, and lost wages for both the patient and their caregivers. "It's just heartbreaking to see families struggling with these diagnoses, not only emotionally but financially," Walz explained. Expanding insurance coverage aims to alleviate some of this burden, making it more financially feasible for individuals and families to access the care they need.

The debate surrounding LB73 is expected to focus on the potential cost implications for insurance companies and employers. Opponents may argue that mandating coverage for expensive tests and treatments will drive up premiums. However, supporters contend that the long-term costs of not addressing Alzheimer's - including increased Medicaid expenditures and lost productivity - far outweigh the initial investment in early detection and treatment.

A committee hearing is scheduled for next week, where legislators will hear testimony from medical professionals, Alzheimer's advocacy groups, insurance representatives, and individuals affected by the disease. This hearing will be a critical juncture in the bill's progress. Several key organizations, including the Nebraska Alzheimer's Association chapter and AARP Nebraska, have publicly endorsed LB73, urging lawmakers to pass the legislation.

Beyond Nebraska, a growing number of states are considering similar measures to expand Alzheimer's coverage. This reflects a national trend towards recognizing the urgency of addressing this debilitating disease and ensuring that individuals have access to the care they deserve. The outcome of LB73 will likely serve as a benchmark for other states grappling with this same challenge. The conversation isn't just about insurance; it's about investing in the future health and well-being of Nebraska's aging population.